These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 1355645)
1. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Green CP; Price JF Arch Dis Child; 1992 Aug; 67(8):1014-7. PubMed ID: 1355645 [TBL] [Abstract][Full Text] [Related]
2. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Carlsen KH; Røksund O; Olsholt K; Njå F; Leegaard J; Bratten G Eur Respir J; 1995 Nov; 8(11):1852-5. PubMed ID: 8620951 [TBL] [Abstract][Full Text] [Related]
3. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol. Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526 [TBL] [Abstract][Full Text] [Related]
4. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Simons FE; Gerstner TV; Cheang MS Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940 [TBL] [Abstract][Full Text] [Related]
5. Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses. de Benedictis FM; Tuteri G; Pazzelli P; Niccoli A; Mezzetti D; Vaccaro R Eur Respir J; 1996 Oct; 9(10):2099-103. PubMed ID: 8902473 [TBL] [Abstract][Full Text] [Related]
6. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
8. Duration of protection by inhaled salmeterol in exercise-induced asthma. Anderson SD; Rodwell LT; Du Toit J; Young IH Chest; 1991 Nov; 100(5):1254-60. PubMed ID: 1682113 [TBL] [Abstract][Full Text] [Related]
9. Sustained protection against distilled water provocation by a single dose of salmeterol in patients with asthma. Bootsma GP; Dekhuijzen PN; Festen J; Lammers JW; Mulder PG; van Herwaarden CL Eur Respir J; 1997 Oct; 10(10):2230-6. PubMed ID: 9387945 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Storms W; Chervinsky P; Ghannam AF; Bird S; Hustad CM; Edelman JM; Respir Med; 2004 Nov; 98(11):1051-62. PubMed ID: 15526805 [TBL] [Abstract][Full Text] [Related]
11. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Kemp JP; Dockhorn RJ; Busse WW; Bleecker ER; Van As A Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1612-5. PubMed ID: 7952623 [TBL] [Abstract][Full Text] [Related]
12. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. Derom EY; Pauwels RA; Van der Straeten ME J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164 [TBL] [Abstract][Full Text] [Related]
13. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline. Richter K; Janicki S; Jörres RA; Magnussen H Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726 [TBL] [Abstract][Full Text] [Related]
14. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Edelman JM; Turpin JA; Bronsky EA; Grossman J; Kemp JP; Ghannam AF; DeLucca PT; Gormley GJ; Pearlman DS Ann Intern Med; 2000 Jan; 132(2):97-104. PubMed ID: 10644288 [TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects. Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226 [TBL] [Abstract][Full Text] [Related]
16. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. Verberne AA; Hop WC; Bos AB; Kerrebijn KF J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):127-34. PubMed ID: 8093705 [TBL] [Abstract][Full Text] [Related]
17. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Grove A; Lipworth BJ; Reid P; Smith RP; Ramage L; Ingram CG; Jenkins RJ; Winter JH; Dhillon DP Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction. Schaanning J; Vilsvik J; Henriksen AH; Bratten G Ann Allergy Asthma Immunol; 1996 Jan; 76(1):57-60. PubMed ID: 8564629 [TBL] [Abstract][Full Text] [Related]
19. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma. Simons FE; Soni NR; Watson WT; Becker AB J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease. Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L Respiration; 2001; 68(5):452-9. PubMed ID: 11694805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]